Atossa Therapeutics (ATOS) Notes Payables (2011 - 2012)
Atossa Therapeutics (ATOS) posted quarterly Notes Payables of $80453.0 for Q3 2012, up 1484.34% quarter-over-quarter from $5078.0 in Q4 2011.
Atossa Therapeutics (ATOS) Notes Payables (2011 - 2012) Analysis & Trends
Atossa Therapeutics (ATOS) has reported Notes Payables for 2 consecutive years, with $80453.0 the latest figure, recorded in Q3 2012.
- In Q3 2012, Notes Payables changed N/A year-over-year to $80453.0; the TTM figure through Sep 2012 stood at $80453.0 (changed N/A YoY), while the FY2011 annual figure was $5078.0, changed N/A from the prior year.
- Notes Payables climbed to $80453.0 in Q3 2012 per ATOS's latest filing, from $5078.0 in the prior quarter.
- Across five years, Notes Payables topped out at $80453.0 in Q3 2012 and bottomed at $5078.0 in Q4 2011.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.90 Bn | 131.05 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.10 Bn | 78.11 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.56 Bn | 60.37 Bn | 1.37 Bn |
| 4 | Moderna | 55.82 Bn | 50.68 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.14 Bn | 37.04 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.67 Bn | 28.36 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.74 Bn | 9.35 Bn | 668.28 Mn |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.38 Bn | 26.54 Bn | - |
| 10 | Atossa Therapeutics | 23.07 Mn | 23.07 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2012 | 80,453.00 |
| Dec 31, 2011 | 5,078.00 |